Aimei responded to the controversy of the "child face needle" agency rights: it is deemed that the other party has actually breached the contract, and everything is subject to the facts and legal basis.

On the evening of July 21st, Jiangsu Wuzhong announced that its holding subsidiary, Dato Medical, had received a "Termination Letter" from South Korean company Regen on the 18th, unilaterally terminating the exclusive distribution agreement for the "AestheFill" product in China. Earlier, the Meikai Guest had completed the acquisition of South Korean company Regen. Regarding this termination, on the evening of July 21st, Jiangsu Wuzhong stated in a public statement that the termination letter seriously violated business ethics.